RAAS Inhibitors and Risk of Covid-19. Reply

N Engl J Med. 2020 Nov 12;383(20):1993-1994. doi: 10.1056/NEJMc2030446. Epub 2020 Oct 27.

Authors

Harmony R Reynolds¹, Samrachana Adhikari¹, Eduardo Iturrate¹

Affiliation

¹ New York University Grossman School of Medicine, New York, NY harmony.reynolds@nyulangone.org.

PMID: 33108107
DOI: 10.1056/NEJMc2030446

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections* / epidemiology
Humans
Pandemics*
Pneumonia, Viral* / epidemiology
Renin-Angiotensin System
SARS-CoV-2